4//SEC Filing
Chen Hongming 4
Accession 0001179110-20-010709
CIK 0001479419other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 8:30 PM ET
Size
5.2 KB
Accession
0001179110-20-010709
Insider Transaction Report
Form 4
Chen Hongming
Chief Scientific Officer10% Owner
Transactions
- Award
Common Stock
2020-10-26+61,000→ 163,849 total
Footnotes (2)
- [F1]On June 25, 2020, the reporting person was granted performance-based restricted stock unit ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued employment with the Issuer, the RSUs will vest as to 50% of the shares underlying the RSUs on October 26, 2021, the first anniversary of the achievement of the performance condition, and as to the remaining 50% of the shares underlying the RSUs on October 26, 2022, the second anniversary of the achievement of the performance condition.
- [F2]Includes 77,000 unvested RSUs.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001710697
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 8:30 PM ET
- Size
- 5.2 KB